Faculty
Khatereh Ahmadi Ph.D.
Head of Search and Evaluation, BD&L, Europe and Middle East
MSD
Agnès Arbat, M.D.
Founder & CEO
OXOLIFE
Ion Arocena
CEO
Asebio
Emmanuelle Astoul, Ph.D.
Interim Head of Translation
Wellcome Sanger Institute
Rita Balice-Gordon, Ph.D.
CEO
Muna Therapeutics
Laurence Barker, Ph.D.
Partner
Dementia Discovery Fund
Joshua Berlin
Head of Corporate Alliances & Business Development
BioCentury Inc.
Karen Bernstein, Ph.D.
Co-Founder & Chairman
BioCentury Inc.
Joan Perelló Bestard, Ph.D.
CEO
Sanifit
Maina Bhaman
Partner
Sofinnova Partners
Steven Biesmans
Principal
UCB Ventures
Kate Bingham
Managing Partner
SV Health Investors
Stéphane Boissel
President and CEO
SparingVision
Christoph Broja
Managing Director
EQT Life Science
Claire Brown, Ph.D.
Partner
Oxford Science Enterprises
Roel Bulthuis
Managing Partner
Syncona Investment Management Ltd.
John Cassidy
General Partner
Kindred Capital
Jean-Philippe Combal
CEO
Vivet Therapeutics
Matt Cooper, Ph.D.
Founder & CEO
Sitala Ltd.
Bianca Coulter
Founder & CEO
Coulter Partners
Susana de Antonio
Head of Listing Euronext Brussels
Euronext N.V.
Arno de Wilde, M.D., Ph.D.
Partner
EQT Life Sciences
Alexander Demoulin
Associate
Bioqube Ventures
Vishal Doshi
Chairman & CEO
AUM Biosciences
Gabriela Ecco
Senior Associate
+ND Capital
Matthias Evers, Ph.D.
Chief Business Officer
Evotec
Simone Fishburn, Ph.D.
VP & Editor in Chief
BioCentury Inc.
David Flores
Co-Founder, President & CEO
BioCentury Inc.
Paulo Fontoura, M.D., Ph.D.
Global Head and SVP, Neuroscience, Immunology, Ophthalmology, Infectious and Rare Diseases
Roche
Arthur Franken
General Partner
Gilde Healthcare
Gemma Game
Head, Healthcare Strategy & Senior Portfolio Manager
Norges Bank Investment Management
Javier García
Chairman
Viralgen
Rowan Gardner
Co-Founder and Chief Business & Investment Officer
PrecisionLife
Caroline Gaynor
Partner
Lightstone Ventures
Hakan Goker, Ph.D.
Managing Director
M Ventures
Anne Grahl
Associate
Pureos Bioventures
Jason Hafler, Ph.D.
Managing Director
Sanofi Ventures
Stephen Hansen
Director of Biopharma Intelligence
BioCentury Inc.
Baruch Harris, Ph.D.
Chief Operating Officer
Pretzel Therapeutics
Susan Hill, Ph.D.
CEO
Mestag Therapeutics
Echo Hindle-Yang
Founder & CEO
MSQ Ventures
Kinam Hong, M.D.
Partner
Sofinnova Partners
Joe Hopcraft
Senior Client Partner
IQVIA
Ane Insausti
Deputy of Economic Development and Strategic Projects
Gipuzkoa
Joël Jean-Mairet, Ph.D.
Managing Partner
Ysios Capital
Emma Johnson
Investment Manager
British Patient Capital
Frank Kalkbrenner, Ph.D.
Global Head
Boehringer Ingelheim Venture Fund
David Ke
Managing Director
J.P. Morgan
Simon Kerry, Ph.D.
CEO
Curve Therapeutics
Vanessa King, Ph.D.
Biotech CEO, Founder and Board Member
Max Klement, Ph.D.
Principal Venture Investments
Novo Holdings
Edward Kliphuis
Partner
Sofinnova Partners
Selina Koch, Ph.D.
Executive Editor, Head of Intelligence & Research
BioCentury Inc.
Mark Kotter
Founder and CEO
bit bio
Sebastian Kreuz, Ph.D.
Executive Director
Boehringer Ingelheim Venture Fund
Nilesh Kumar, Ph.D.
Private Biotech Investor
Wellington Management
Dima Kuzmin
Managing Partner
4BIO Capital
Emmanuel Lacroix, Ph.D.
CEO
NeuVasQ Biotechnologies
Andrew Lam, PharmD.
Managing Director, Head of Biotech
Ally Bridge
Franck Le Deu
Senior Partner & Co-Leader of Asia Life Sciences Practice
McKinsey & Company
Ingo Lehrke
Chief Business Officer
Tubulis
Nick Lench, Ph.D.
Executive Director
Nucleic Acid Therapy Accelerator
Chiara Liberati
Managing Director
Golgi Neurosciences
Therese Maria Liechtenstein, Ph.D.
Investment Director
M Ventures
Paul Little, Ph.D.
CEO
Vesper Bio
Brian Liu, M.D.
Managing Director
Longitude Capital
Ilise Lombardo, M.D.
CEO
Noema Pharma
Joseph Lydon, Ph.D.
Partner
McKinsey & Company
Claire Macht
Director, European Portfolio
EBD Group
Fiona MacLaughlin, Ph.D.
Senior Director, Venture Investments
Johnson & Johnson Development Corporation (JJDC)
William Maier, Ph.D.
VP & Head, Center for Rare Disease
ICON
Giovanni Mariggi, Ph.D.
Partner
Medicxi
Ryan Martin
Senior Associate
Oxford Finance
Jennifer McMahon
Partner, Seroba and
International Chair, Level 20 Europe
Rachel Mears
Partner
Jeito Capital
Michael Meyers
Vice Chairman & Head of M&A and Strategic Advisory Services
H.C. Wainwright
Lauren Mifflin, Ph.D.
VP, Company Creation
Frazier Healthcare
Michelle Morgan, VP, IQVIA
VP
IQVIA
Joep Muijrers, Ph.D.
General Partner
Gilde Healthcare
Arantza Muriana
Co-Founder, R&D Director & CEO of USA
Biobide
Mitchell Mutz, Ph.D.
Entrepreneur Partner
Vivo Capital
Søren Møller
Managing Partner
Novo Seeds
Rabab Nasrallah, Ph.D.
Principal
EarlyBird Venture Capital
Carole Nuechterlein
Head, Roche Venture Fund
Roche
Paula Olazabal
Partner & Head of ESG
Ysios Capital
Cristina Oyon
Director, Technology, Innovation and Sustainability
SPRI (The Basque Business Development Agency)
Greg Parekh, Ph.D.
Founder & Managing Partner
New Rhein Healthcare Investors
Ksenija Pavletic
Partner
Jeito Capital
Michael Pehl
CEO
Adcendo
Elisa Petris
Lead Partner
Syncona Investment Management
Catherine Pickering, Ph.D.
Director & CEO
iOnctura
Eric Pierce
Executive Director, Corporate Alliances
BioCentury Inc.
Jorge Presa
CEO
Cyber Surgery
Nina Rawal, Ph.D.
Partner & Co-Head, Impact Ventures
Trill Impact
Alberto Sanz Serrano
Director, Finance & Investor Relations
Invest in Spain
Philip Schwab, Ph.D.
Senior Director, Government Affairs, Region Europe
AbbVie
Nerida Scott, Ph.D.
Regional Head, EMEA
Johnson & Johnson Innovation
Naveed Siddiqi
Senior Partner
Novo Holdings
Josefine Sommer
Partner
Sidley
Bobby Soni, Ph.D.
Chief Business Officer
BioInnovation Institute
Sophie Stegen
Head of Listing Belgium
Euronext N.V.
Campbell Stewart M.D.
VP
Novo Holdings
Masha Stromme, Ph.D.
Co-Chair
PAACS Invest
Anamaria Sudarov, Ph.D.
Managing Director
MTS Health Partners
Haru Sugino, Ph.D.
Global Head, Search and Evaluation, Global Business Development
Otsuka Pharmaceutical
Paul Peter Tak, M.D., Ph.D.
President and CEO
Candel Therapeutics
Christina Takke, Ph.D.
Managing Partner
V-Bio Ventures
Arantza Tapia
Minister for Economic Development, Sustainability and the Environment
Basque Government
Karen Tkach Tuzman, Ph.D.
Director of Biopharma Intelligence and Head of Discovery and Preclinical Research
BioCentury Inc.
Jonathan Tobin
Partner
Brandon Capital
Martin Turner, Ph.D.
Associate Director, Policy, Public Affairs & Investor Relations
BIA (U.K. BioIndustry Association)
Jérôme Van Biervliet, Ph.D.
Managing Director
VIB
Erik van den Berg
CEO
Memo Therapeutics
Bonnie van Wilgenburg
Principal
Monograph Capital Advisors
Valerie Vanhooren, Ph.D.
Co-Founder & CEO
Ona Therapeutics
Jimmy Vanhove
CEO
Viralgen
Roderick Verhelst
Principal
Bioqube Ventures
Miquel Vila-Perelló, CEO, Splice Bio
CEO
Splice Bio
Jessica Vitos, Ph.D.
Senior Manager, Innovation, Grifols, and
Board Member, YVC Collective
Anne Vroon
VP of Business Development
Genmab
Karen Wagner, Ph.D.
Managing Partner
Ysios Capital
Nathalie Ter Wengel, M.D.
European Lead, Worldwide Business Development
Pfizer
Michael White
Market Manager & Head of Life Sciences, EMEA
HSBC Innovation Bank
Erica Whittaker, Ph.D.
VP & Head Corporate Venture Fund
UCB Ventures
Kathleen Williams, Ph.D.
Partner
Nutter McClennen & Fish LLP
Marietta Wu, M.D., Ph.D.
Managing Director
Quan Capital
Shanshan Xu, M.D., Ph.D.
Special Advisor, BioNTech, and CEO
Bambusa Therapeutics
Alexandra Zemp, Ph.D.
Partner
McKinsey & Company